Article Text

other Versions

PDF
Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer
  1. Marianne Jensen Hjermstad1,2,
  2. Stein Kaasa2,3,
  3. Augusto Caraceni2,4,
  4. Jon H Loge1,5,
  5. Tore Pedersen6,7,
  6. Dagny Faksvåg Haugen2,8,9 and
  7. Nina Aass1,10
  8. on behalf of the European Palliative Care Research Collaborative (EPCRC)
    1. 1Department of Oncology, Regional Advisory Unit for Palliative Care, Oslo University Hospital, Oslo, Norway
    2. 2Department of Cancer Research and Molecular Medicine, Faculty of Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
    3. 3Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
    4. 4Department of Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS, Istituto Nazionale Dei Tumori, Milano, Italy
    5. 5Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway
    6. 6Bjørknes University College, Oslo, Norway
    7. 7National Institute of Occupational Health, Oslo, Norway
    8. 8Regional Centre of Excellence for Palliative Care, Western Norway, Haukeland University Hospital, Bergen, Norway
    9. 9Department of Clinical Medicine K1, University of Bergen, Bergen, Norway
    10. 10Faculty of Medicine, University of Oslo, Oslo, Norway
    1. Correspondence to Dr Marianne Jensen Hjermstad, Department of Oncology, Regional Advisory Unit for Palliative Care, Oslo University Hospital, Ullevål, Box 4956, Nydalen, Oslo 0424, Norway; marianne.j.hjermstad{at}ntnu.no

    Abstract

    Objectives Breakthrough cancer pain (BTP) represents a treatment challenge. Objectives were to examine the prevalence and characteristics of BTP in an international sample of patients with cancer, and to investigate the relationship between BTP and quality of life (QoL).

    Methods This was an observational cross-sectional multicentre study. Participating patients completed self-report questionnaires on a touch-screen laptop computer, including the Brief Pain Inventory, Alberta Breakthrough Pain Assessment Tool (ABPAT) and European Organisation for Research and Treatment of Cancer 30-item Core Quality of Life Questionnaire (EORTC QLQ-C30). The study was performed in 17 centres in 8 countries and involved 4 languages (Norwegian, Italian, German and English).

    Results Records from a convenience sample of 978 patients with advanced cancer were analysed; mean age was 62.2 years, 48.3% were women and 84.4% had metastatic disease. A total of 296 patients (30%) had no pain, defined as worst pain in the past 24 hours <1 on a 0–10 scale. Of the 682 patients with a pain score ≥1, 393 (58%) reported no BTP on the screening item, while 289 (30%) confirmed flare ups of BTP. Patients with BTP reported significantly higher pain intensity scores (<0.001) than patients without BTP; 57.1% of patients rated BTP at its worst as being severe: ≥7 on a 0–10 scale. Time from onset to peak intensity was <10 min for 42.9%, and average time to pain relief was 27.1 min. BTP was commonly triggered by medication wearing off (28%). Patients with BTP had significantly worse mean outcomes on 10 of 15 functional and symptom scales of the EORTC QLQ-C30 (<0.001). Severe pain intensity in the last week was a powerful predictor of BTP (OR 4.1) and poor QoL (OR 1.9).

    Conclusions BTP is highly prevalent with prolonged episodes despite analgaesics, and has a pervasive impact on QoL. Patients reporting high pain intensity should be carefully evaluated for BTP and efficacy of analgaesic treatment, to provide optimal pain management and improve QoL.

    Trial registration number NCT00972634; Results.

    • Cancer
    • Pain
    • Quality of life
    • Clinical assessment
    • Breakthrough cancer pain
    • Pain assessment
    • Received 11 March 2015.
    • Revision received 19 April 2016.
    • Accepted 31 May 2016.

    Statistics from Altmetric.com

    • Received 11 March 2015.
    • Revision received 19 April 2016.
    • Accepted 31 May 2016.
    View Full Text

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.